Literature DB >> 15165512

Identification of kinase inhibitors by an ATP depletion method.

Pirthipal Singh1, Benedict J Harden, Benjamin J Lillywhite, Peter M Broad.   

Abstract

ATP is one of the substrates of luciferase. ATP concentrations can be measured by quantitating the light output from a luciferase reaction. As kinases also use ATP, it is possible to assay kinase activity through the loss of luminescence in a coupled luciferase reaction. We have applied this luminescence-based ATP depletion approach to a model serine/threonine kinase. We find that the method may be run as an endpoint assay, in which ATP detection reagents (containing luciferase and luciferin) are added at the end of the reaction, or in a kinetic mode, where the ATP detection reagents are present throughout the reaction. The ATP depletion approach is capable of detecting kinase inhibitors. Six inhibitors of the model kinase, previously identified using other screening methods, are also active in the luminescence-based approach and display a similar rank order of potency. An advantage of the method is that kinase inhibitors, because they increase luminescence (by reversing the enzyme-dependent loss of signal), are immediately distinguishable from compounds such as luciferase inhibitors and luminescence quenchers, which further reduce the luminescence. The compound collections that we screened were rich in compounds that reduced luminescence. Compounds that have dual kinase and luciferase inhibitory activity, or kinase inhibitory activity combined with luminescence quenching, might be missed by being classified as false negatives. We show that the kinetic form of the assay can be used to minimize this possibility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165512     DOI: 10.1089/154065804323056503

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  9 in total

1.  Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Jian-kang Jiang; Matthew B Boxer; Matthew G Vander Heiden; Min Shen; Amanda P Skoumbourdis; Noel Southall; Henrike Veith; William Leister; Christopher P Austin; Hee Won Park; James Inglese; Lewis C Cantley; Douglas S Auld; Craig J Thomas
Journal:  Bioorg Med Chem Lett       Date:  2010-04-11       Impact factor: 2.823

2.  A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution.

Authors:  Douglas S Auld; Ya-Qin Zhang; Noel T Southall; Ganesha Rai; Marc Landsman; Jennifer MacLure; Daniel Langevin; Craig J Thomas; Christopher P Austin; James Inglese
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

3.  Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

Authors:  Karen M Kleman-Leyer; Tony A Klink; Andrew L Kopp; Thane A Westermeyer; Mark D Koeff; Brad R Larson; Tracy J Worzella; Cori A Pinchard; Sebastianus A T van de Kar; Guido J R Zaman; Jorrit J Hornberg; Robert G Lowery
Journal:  Assay Drug Dev Technol       Date:  2009-02       Impact factor: 1.738

4.  Comparison of bioluminescent kinase assays using substrate depletion and product formation.

Authors:  Cordelle Tanega; Min Shen; Bryan T Mott; Craig J Thomas; Ryan MacArthur; James Inglese; Douglas S Auld
Journal:  Assay Drug Dev Technol       Date:  2009-12       Impact factor: 1.738

5.  Dietary fructose inhibits lactation-induced adaptations in rat 1,25-(OH)₂D₃ synthesis and calcium transport.

Authors:  Veronique Douard; Takuji Suzuki; Yves Sabbagh; Jacklyn Lee; Sue Shapses; Sheldon Lin; Ronaldo P Ferraris
Journal:  FASEB J       Date:  2011-10-28       Impact factor: 5.191

Review 6.  Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology.

Authors:  Natasha Thorne; James Inglese; Douglas S Auld
Journal:  Chem Biol       Date:  2010-06-25

7.  Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Matthew B Boxer; Jian-kang Jiang; Matthew G Vander Heiden; Min Shen; Amanda P Skoumbourdis; Noel Southall; Henrike Veith; William Leister; Christopher P Austin; Hee Won Park; James Inglese; Lewis C Cantley; Douglas S Auld; Craig J Thomas
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

8.  A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.

Authors:  Althea A Capul; Juan Carlos de la Torre
Journal:  Virology       Date:  2008-10-16       Impact factor: 3.616

9.  Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.

Authors:  Sabrina R Mackinnon; Tobias Krojer; William R Foster; Laura Diaz-Saez; Manshu Tang; Kilian V M Huber; Frank von Delft; Kent Lai; Paul E Brennan; Gustavo Arruda Bezerra; Wyatt W Yue
Journal:  ACS Chem Biol       Date:  2021-03-16       Impact factor: 5.100

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.